Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

DFDS A/S provides passenger and freight shipping services, and offers shipping related logistics solutions.  The Company focuses on two business divisions: DFDS Tor Line operates roro liner traffic in the North Sea, and DFDS Seaways runs overnight cruise ferries between cities in Northern Europe.  DFDS sells to customers with large shipping requirements and to car traveling tourists.

<ul>
 <li>
Turnaround and Operating Inflection Underway: Following a severe margin compression in FY2024 and FY2025—which culminated in a net loss of DKK -427m in 2025 due to Mediterranean freight headwinds, Channel price competition, and cost inflation—DFDS is showing clear signs of an operational rebound. Q2 2026 results demonstrated strong positive operating leverage with group revenue reaching DKK 8,584m, net income returning to profitability at DKK 165m, and management subsequently raising full-year 2026 EBIT guidance to DKK 1.2bn–1.4bn.</li>
 <li>
Network Expansion and End-to-End Intermodal Integration: The strategic acquisition and integration of Ekol Logistics' international transport network in late 2024 has expanded DFDS's footprint across the Mediterranean and Continental Europe. By combining proprietary Ro-Ro shipping routes with door-to-door intermodal road and rail networks connecting Türkiye to European manufacturing hubs, DFDS has reinforced its customer retention and terminal density, transforming into an integrated European transport infrastructure provider.</li>
 <li>
Compelling Deep-Value Valuation Balanced by Deleveraging Priorities: DFDS trades at an attractive cyclical discount of ~0.6x–0.7x P/B and ~5.5x normalized forward EV/EBITDA, earning a maximum Value Smartscore of 5/5. However, capital returns remain constrained following dividend suspension in FY2024–FY2025 as the newly appointed CEO Michael Hansen and CFO Karen Dyrskjøt Boesen focus on operational restructuring under the 'Logistics Boost' program and reducing financial leverage toward the target threshold of 2.5x net debt-to-EBITDA.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Turnaround and Operating Inflection Underway: Following a severe margin compression in FY2024 and FY2025—which culminated in a net loss of DKK -427m in 2025 due to Mediterranean freight headwinds, Channel price competition, and cost inflation—DFDS is showing clear signs of an operational rebound. Q2 2026 results demonstrated strong positive operating leverage with group revenue reaching DKK 8,584m, net income returning to profitability at DKK 165m, and management subsequently raising full-year 2026 EBIT guidance to DKK 1.2bn–1.4bn.
  
Network Expansion and End-to-End Intermodal Integration: The strategic acquisition and integration of Ekol Logistics' international transport network in late 2024 has expanded DFDS's footprint across the Mediterranean and Continental Europe. By combining proprietary Ro-Ro shipping routes with door-to-door intermodal road and rail networks connecting Türkiye to European manufacturing hubs, DFDS has reinforced its customer retention and terminal density, transforming into an integrated European transport infrastructure provider.
  
Compelling Deep-Value Valuation Balanced by Deleveraging Priorities: DFDS trades at an attractive cyclical discount of ~0.6x–0.7x P/B and ~5.5x normalized forward EV/EBITDA, earning a maximum Value Smartscore of 5/5. However, capital returns remain constrained following dividend suspension in FY2024–FY2025 as the newly appointed CEO Michael Hansen and CFO Karen Dyrskjøt Boesen focus on operational restructuring under the 'Logistics Boost' program and reducing financial leverage toward the target threshold of 2.5x net debt-to-EBITDA.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Equity Capital Markets and Advisory Business, Auctus Advisors

Auctus Advisors

Equity Capital Markets and Advisory Business

Auctus Advisors is a specialist Equity Capital Markets and Advisory business with a focus in the Energy Sector. The partners have complementary skill sets, with decades of experience across Equity Capital Markets, Investment Banking and the Energy industry. We have worked at Société Générale, Canaccord Capital, BMO Capital Markets and Schlumberger. Most recently we have worked together for many years at GMP FirstEnergy. Auctus has been set up at the beginning of a new decade in which we see significant opportunities in the Energy space. Globally, demand for energy is at record levels and continues to grow. Conversely, investment in traditional energy sources has been severely constrained. We believe this imbalance creates opportunities for both companies and investors. Auctus provides Corporate Broking, Equity Research and Investment Banking services.

Thematic (Sector/Industry)

<ul><li>AUCTUS PUBLICATIONS ________________________________________ CanCambria Energy (CCEC CN)C; Target price of C$2.90 per share: Equity raise to fund shallow oil seismic – CanCambria has raised C$6.9 mm through an offering of 23.0 mm units at C$0.30 per unit, each comprising one share and one warrant exercisable at C$0.40 per share for 36 months.</li><li>Proceeds fund a proprietary 3D seismic survey over the Soltvadkert/Tázlár/Alpár (STA) shallow oil fairway (C$4 mm in 4Q26 in our model) and the de-risking of ten shallow oil prospects.</li><li>There are 400 legacy wells across CanCambria's licence, and neighbouring analogue fields have collectively produced over 160 mmboe from 15 fields, with oil gravities of 22–40° API.</li></ul>

AUCTUS PUBLICATIONS ________________________________________ CanCambria Energy (CCEC CN)C; Target price of C$2.90 per share: Equity raise to fund shallow oil seismic – CanCambria has raised C$6.9 mm through an offering of 23.0 mm units at C$0.30 per unit, each comprising one share and one warrant exercisable at C$0.40 per share for 36 months.Proceeds fund a proprietary 3D seismic survey over the Soltvadkert/Tázlár/Alpár (STA) shallow oil fairway (C$4 mm in 4Q26 in our model) and the de-risking of ten shallow oil prospects.There are 400 legacy wells across CanCambria's licence, and neighbouring analogue fields have collectively produced over 160 mmboe from 15 fields, with oil gravities of 22–40° API.

Asian Hedge Fund Manager, Long Short Equity, Macro

David Mudd

Cross Asset Strategy

<ul>
<li>DC company share prices are rolling over, foreshadowing increasing pressure on their hyperscaler customers.  Since the July swoon in semiconductor stocks, the DC sector has underperformed both hyperscalers and semiconductors.</li>
<li>DC players face strong headwinds on multiple fronts, including high leverage/circular financing, supply chain delays, public opposition, and questions about aggressive forecasts of future compute demand.</li>
<li>Leverage is the most prominent risk in the DC sector, with questions looming about completion dates and customers' ability to meet their contracted offtake agreements.</li>
</ul>


DC company share prices are rolling over, foreshadowing increasing pressure on their hyperscaler customers.  Since the July swoon in semiconductor stocks, the DC sector has underperformed both hyperscalers and semiconductors.
DC players face strong headwinds on multiple fronts, including high leverage/circular financing, supply chain delays, public opposition, and questions about aggressive forecasts of future compute demand.
Leverage is the most prominent risk in the DC sector, with questions looming about completion dates and customers' ability to meet their contracted offtake agreements.


DATA CENTER SECTOR: From the Tip of the Spear to Canary in the Coal Mine

Director, Sentiment Matters

Lars Kreckel

Director

The mood of the market, mapped and decoded

Sentiment Matters

Investor sentiment is the overall mood of investors - how bullish or bearish they are on a market or asset.

Sentiment is part of every investor’s investment process. Whether for macro investors, stock pickers, or thematic investors, it matters whether a position is consensus or contrarian.

<ul>
<li>
Buy Side Sentiment Tracker: we aggregate asset-allocation views from 54 top asset managers across 73 assets, based on 1,400+ individual views.</li>
<li>
Bullish, but not extreme: Risk appetite is high and rising, yet equity downgrades and resilient sovereign demand show the Buy Side is far from universally risk-on.</li>
<li>
Max Contrarian: Infrastructure, Industrial Metals and Gold are most popular; Swiss Franc, Cash and Consumer Staples are least popular.</li>
</ul>



Buy Side Sentiment Tracker: we aggregate asset-allocation views from 54 top asset managers across 73 assets, based on 1,400+ individual views.

Bullish, but not extreme: Risk appetite is high and rising, yet equity downgrades and resilient sovereign demand show the Buy Side is far from universally risk-on.

Max Contrarian: Infrastructure, Industrial Metals and Gold are most popular; Swiss Franc, Cash and Consumer Staples are least popular.


Sentiment Matters: Buy Side Sentiment Tracker - October 2026

Research from Redeye, Redeye AB

Redeye

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

FluoGuide A/S is a clinical-stage biotechnology company that develops drugs for precision cancer surgery. The company's lead product, FG001, is designed to improve surgical precision by illuminating cancer cells intraoperatively. This technology aims to reduce the risk of local recurrence, minimize surgical complications, and lower healthcare costs. FG001 has been studied in aggressive brain cancer (high-grade glioma), lung cancer, and head and neck cancer. Beyond surgical guidance, FG001 also has potential therapeutic applications as a photosensitizer in photothermal and photodynamic therapies. The company has collaborations with medical technology companies to advance the development and commercialization of its products.

<ul><li>Redeye comments on FluoGuide's announcement that the first patient has been enrolled in FG001-CT-006, the company's US Phase II trial of FG001 in newly diagnosed high-grade glioma.</li><li>The trial is designed to gather sufficient clinical data to support future registration of FG001.</li><li>We view the enrollment as an important execution milestone that marks the company's transition from regulatory planning to clinical delivery in its lead indication.</li></ul>

Redeye comments on FluoGuide's announcement that the first patient has been enrolled in FG001-CT-006, the company's US Phase II trial of FG001 in newly diagnosed high-grade glioma.The trial is designed to gather sufficient clinical data to support future registration of FG001.We view the enrollment as an important execution milestone that marks the company's transition from regulatory planning to clinical delivery in its lead indication.

FluoGuide: First patient enrolled in US Phase II registration-supporting trial